|
Complainant part is expected to be returned for manufacturer review/investigation, but has yet to be received.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
It was reported that on (b)(6) 2021, during spinal fusion surgery the surgeon was impacting a spacer into the patients disc space when the plastic end of the mallet broke off the mallet and fell in the floor.The surgeon immediately flipped over the mallet and finished the process with the metal end of the same mallet.There was no surgical delay.There were no fragments generated.There were no patient consequences.The procedure was successfully completed.Concomitant device reported: unknown spacer (part# unknown, lot# unknown, quantity unknown).This report is for (1) hammer.This is report 1 of 1 for (b)(4).
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: d4 h3, h4, h6: a review of the receiving inspection (ri) for hammer was conducted identifying that lot number e18d10316 was released in a single batch.Batch 1: were released on october 08, 2018 with no discrepancies.Batch 2: released on august 29, 2018 with no discrepancies.As a result, the ri identified no issues during the manufacturing and release of this device that could have contributed to the problem reported by the customer.Visual inspection: the hammer was received at us customer quality (cq).Upon visual inspection, it was observed that the poly cap had broken off from the hammer.The broken poly cap was returned with the device.No other visual defects were observed with the device.Dimensional inspection: no dimensional inspection can be performed due to post-manufacturing damage.Furthermore, the complaint relevant dimensions cannot be checked for dimensional accuracy, because of the design of the device.Document/specification review based on the date of manufacture, the current and the manufactured drawings were reviewed.Investigation conclusion: the complaint condition is confirmed.There is no indication that a design or manufacturing issue has caused the issue and hence the root cause cannot be determined.The potential cause could be due to unintended forces applied to the device.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.D9.
|